InvestorLens

ARQT — ARCUTIS BIOTHERAPEUTICS INC

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ARCUTIS BIOTHERAPEUTICS INC (ARQT)

ARCUTIS BIOTHERAPEUTICS INC (ARQT) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $14M. Across recent filings, tracked investors recorded 7 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ARQT

100
/100
Strong Institutional Accumulation
Added / Increased7
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track ARQT

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

ARQT Ownership Composition

How ARCUTIS BIOTHERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Hedge Funds
68% of tracked value
Institutions
4
tracked investors
Total Reported
$20.5M
combined 13F value
Sectors2
  • Hedge Funds68.0%
  • Other32.0%
Hedge Funds(1)
68.0%
Other(3)
32.0%

Tracked investors reporting ARQT

  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    590.9K
    Value
    $13.9M
    % Portfolio
    0.02%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    98.2K
    Value
    $2.3M
    % Portfolio
    0.00%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    49.3K
    Value
    $1.2M
    % Portfolio
    0.00%
  • Paul Tudor JonesDec 31, 2025
    Tudor Investment Corp
    Shares
    106.1K
    Value
    $3.1M
    % Portfolio
    0.01%

Recent activity

Frequently asked questions

How many institutional investors hold ARQT?
4 tracked institutional investors disclosed a position in ARQT (ARCUTIS BIOTHERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of ARQT?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ARQT, valued at $14M.
Did institutional ownership of ARQT increase or decrease?
Across recent 13F filings, tracked investors recorded 7 new positions, 0 increased, 0 reduced, and 0 fully exited ARQT.
Where does this ARQT ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.